Trending...
- Pacific Surfliner Service Temporarily Suspended South of Irvine Station
- Are Scary Movies Mentally Designed By The Horrific Environment Within Society: New Premiere Smile
- California Empowers Students
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that senior management is scheduled to present at the following investor conferences:
Event: Wells Fargo Healthcare Conference
Date: Thursday, September 8, 2022
Time: 10:25 a.m. Eastern Time
Event: Morgan Stanley Healthcare Conference
Date: Monday, September 12, 2022
Time: 11:05 a.m. Eastern Time
Interested parties may access a live and archived webcast of each presentation by visiting the Axonics investor relations website.
More on The Californer
About Axonics
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2021 Deloitte Technology Fast 500™ and the 2022 Financial Times ranking of the 500 fastest growing companies in the Americas.
More on The Californer
Axonics sacral neuromodulation (SNM) systems provide patients suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company's best-in-class urethral bulking hydrogel, Bulkamid®, provides safe and durable symptom relief to women with stress urinary incontinence (SUI). Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 29 million women in the U.S. alone. Axonics' clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit www.axonics.com.
Contacts
Neil Bhalodkar
949-336-5293
ir@axonics.com
Event: Wells Fargo Healthcare Conference
Date: Thursday, September 8, 2022
Time: 10:25 a.m. Eastern Time
Event: Morgan Stanley Healthcare Conference
Date: Monday, September 12, 2022
Time: 11:05 a.m. Eastern Time
Interested parties may access a live and archived webcast of each presentation by visiting the Axonics investor relations website.
More on The Californer
- THINKWARE Announces Amazon Prime Fall Promotion
- Five New Members Join Ventura College Foundation Board
- One Park Technologies Fuel Its Growth in Texas
- Flutter vs. React Native — What to сhoose in 2021?
- General Micro Systems (GMS) Introduces Lightweight, Rugged, "X9 Spider Wearable" Mobile Computer with Eight I/O "Legs" and Optional AI GPGPU
About Axonics
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2021 Deloitte Technology Fast 500™ and the 2022 Financial Times ranking of the 500 fastest growing companies in the Americas.
More on The Californer
- Key California Alliance Members Declare 'NO ON PROPOSITION 1!'
- Sara Abbas Honored with Prestigious Powerhouse Global Women Award Among Other Top Awardees of 2022
- Best of HouseKeeping 2022 Award-Winner, The Bristol Hotel, Celebrates Fall Season with Limited Time Packages - Explore San Diego's Historic Gaslamp District for a Boutique Experience in the Big City
- Aria Systems Awarded "Best New Catalyst in Show" at TM Forum's Digital Transformation World
- AesirX DAM launches: a new Free Open Source 'Community' Digital Asset Management tool with 100MB of free cloud storage!
Axonics sacral neuromodulation (SNM) systems provide patients suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company's best-in-class urethral bulking hydrogel, Bulkamid®, provides safe and durable symptom relief to women with stress urinary incontinence (SUI). Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 29 million women in the U.S. alone. Axonics' clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit www.axonics.com.
Contacts
Neil Bhalodkar
949-336-5293
ir@axonics.com
Filed Under: Business
0 Comments
Latest on The Californer
- Colorado's Largest Witch Festival, "WitchFest", October 21-22
- New Smart Mouse uses Artificial Intelligence (AI) and Voice Recognition Technology to Improve Business Productivity
- GLASSDOOR APPOINTS DANNY GUILLORY AS CHIEF PEOPLE OFFICER
- One Mind at Work, Columbia University Mental Health + Work Design Lab, and Ethisphere announce the Mental Health at Work Index™, the first of its kind comprehensive strategy to not only measure but also improve and innovate workplace mental health
- Wastewater Facilities Turn to Greasezilla® for Upstream Fats, Oils & Grease Solution and Revenue Generation
- Innovative Computing Systems Sponsors iManage ConnectLive 2022
- Presenting Traveling Hands Massage
- Amplitude Welcomes Tifenn Dano Kwan as Chief Marketing Officer
- Solina to acquire Saratoga Food Specialties
- RevitaLash® Cosmetics Champions Breast Cancer Awareness, Research, and Support Worldwide with 2022 Pink Program Announcement USA - English USA - English
- Jumio Wins Double Gold in the 10th Annual 2022 CEO World Awards®
- Cohesity Appoints Karen Egan Chief Customer Experience Officer
- ezPaycheck Payroll Software Offers Small Business An Efficient Way to Process Employee Paychecks
- Samsung Electronics Unveils Plans for 1.4nm Process Technology and Investment for Production Capacity at Samsung Foundry Forum 2022
- LEVVELS Inc. introduces MOMENTICA, the future of fandom engagement around the globe through one-of-a-kind digital collectibles
- Local Entrepreneur to Appear on New Reality Show on the BLKGTV App
- BlueSpark Energy Wins the 2022 Oil & Gas Cleantech Challenge
- Nihon Kohden Announced the Release of Life Scope® G7 Patient Monitor
- California Entrepreneur Uses AI Technology To Create Stunning, Lifelike Artwork
- LIFE: The Shyan Selah Show Podcast to be Streamed on Fox Soul/Tubi